nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—psoriatic arthritis—metabolic syndrome X	0.698	1	CtDrD
Auranofin—ALB—metabolic syndrome X	0.237	1	CbGaD
Auranofin—PRDX5—cardiovascular system—metabolic syndrome X	0.00177	0.193	CbGeAlD
Auranofin—PRDX5—kidney—metabolic syndrome X	0.00174	0.189	CbGeAlD
Auranofin—PRDX5—adipose tissue—metabolic syndrome X	0.00157	0.17	CbGeAlD
Auranofin—PRDX5—liver—metabolic syndrome X	0.0011	0.12	CbGeAlD
Auranofin—IKBKB—cardiovascular system—metabolic syndrome X	0.00105	0.114	CbGeAlD
Auranofin—IKBKB—adipose tissue—metabolic syndrome X	0.000927	0.101	CbGeAlD
Auranofin—IKBKB—liver—metabolic syndrome X	0.00065	0.0708	CbGeAlD
Auranofin—ALB—liver—metabolic syndrome X	0.000379	0.0413	CbGeAlD
Auranofin—ALB—Platelet degranulation—IGF2—metabolic syndrome X	0.00011	0.00198	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TGFB1—metabolic syndrome X	0.000108	0.00194	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—AKT1—metabolic syndrome X	0.000108	0.00194	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—metabolic syndrome X	0.000105	0.00188	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—INS—metabolic syndrome X	0.000105	0.00188	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—CCL2—metabolic syndrome X	0.000103	0.00185	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—CRP—metabolic syndrome X	0.000102	0.00183	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—metabolic syndrome X	0.000101	0.00182	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—metabolic syndrome X	0.000101	0.00181	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—APOB—metabolic syndrome X	9.9e-05	0.00178	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—APOA1—metabolic syndrome X	9.86e-05	0.00177	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—CD36—metabolic syndrome X	9.69e-05	0.00174	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—LBP—metabolic syndrome X	9.64e-05	0.00173	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SERPINE1—metabolic syndrome X	9.62e-05	0.00173	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—AKT1—metabolic syndrome X	9.33e-05	0.00167	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—CD36—metabolic syndrome X	9.23e-05	0.00166	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—IRS1—metabolic syndrome X	9.02e-05	0.00162	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—AKT1—metabolic syndrome X	8.99e-05	0.00161	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—INS—metabolic syndrome X	8.52e-05	0.00153	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—APOA1—metabolic syndrome X	8.45e-05	0.00152	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—CCL2—metabolic syndrome X	8.38e-05	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IRS1—metabolic syndrome X	8.29e-05	0.00149	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—AKT1—metabolic syndrome X	8.25e-05	0.00148	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	8.2e-05	0.00147	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—VCAM1—metabolic syndrome X	8.19e-05	0.00147	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—CRP—metabolic syndrome X	8.1e-05	0.00145	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—metabolic syndrome X	8.05e-05	0.00145	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—IRS1—metabolic syndrome X	8.01e-05	0.00144	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PLA2G6—metabolic syndrome X	7.94e-05	0.00142	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—APOA1—metabolic syndrome X	7.83e-05	0.00141	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SERPINE1—metabolic syndrome X	7.83e-05	0.0014	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—metabolic syndrome X	7.74e-05	0.00139	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—metabolic syndrome X	7.71e-05	0.00138	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IRS1—metabolic syndrome X	7.65e-05	0.00137	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—AKT1—metabolic syndrome X	7.63e-05	0.00137	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—AKT1—metabolic syndrome X	7.52e-05	0.00135	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—AKT1—metabolic syndrome X	7.52e-05	0.00135	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—AKT1—metabolic syndrome X	7.52e-05	0.00135	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TRIB3—metabolic syndrome X	7.3e-05	0.00131	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—metabolic syndrome X	7.29e-05	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL18—metabolic syndrome X	7.25e-05	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—metabolic syndrome X	7.2e-05	0.00129	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—metabolic syndrome X	7.2e-05	0.00129	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—IRS1—metabolic syndrome X	7.08e-05	0.00127	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—IGF1—metabolic syndrome X	7.07e-05	0.00127	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—TRIB3—metabolic syndrome X	7.01e-05	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—metabolic syndrome X	6.92e-05	0.00124	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	6.8e-05	0.00122	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—INS—metabolic syndrome X	6.77e-05	0.00122	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—metabolic syndrome X	6.73e-05	0.00121	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—SERPINE1—metabolic syndrome X	6.71e-05	0.0012	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—metabolic syndrome X	6.69e-05	0.0012	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—CCL2—metabolic syndrome X	6.66e-05	0.0012	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	6.51e-05	0.00117	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—AKT1—metabolic syndrome X	6.5e-05	0.00117	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—AKT1—metabolic syndrome X	6.5e-05	0.00117	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—metabolic syndrome X	6.5e-05	0.00117	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—metabolic syndrome X	6.42e-05	0.00115	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—AKT1—metabolic syndrome X	6.42e-05	0.00115	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—metabolic syndrome X	6.39e-05	0.00115	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—metabolic syndrome X	6.36e-05	0.00114	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—AKT1—metabolic syndrome X	6.27e-05	0.00113	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SERPINE1—metabolic syndrome X	6.22e-05	0.00112	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—metabolic syndrome X	6.16e-05	0.00111	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	6.08e-05	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—AKT1—metabolic syndrome X	5.87e-05	0.00105	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—metabolic syndrome X	5.75e-05	0.00103	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—metabolic syndrome X	5.7e-05	0.00102	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—metabolic syndrome X	5.67e-05	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Immune System—LBP—metabolic syndrome X	5.61e-05	0.00101	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—metabolic syndrome X	5.6e-05	0.001	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—metabolic syndrome X	5.5e-05	0.000987	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	5.43e-05	0.000976	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CYBA—metabolic syndrome X	5.43e-05	0.000975	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—metabolic syndrome X	5.43e-05	0.000975	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—metabolic syndrome X	5.4e-05	0.00097	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—metabolic syndrome X	5.4e-05	0.00097	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—metabolic syndrome X	5.36e-05	0.000962	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—metabolic syndrome X	5.36e-05	0.000962	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—metabolic syndrome X	5.31e-05	0.000953	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRS1—metabolic syndrome X	5.3e-05	0.000951	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IRS1—metabolic syndrome X	5.21e-05	0.000935	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	5.15e-05	0.000925	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—metabolic syndrome X	5.09e-05	0.000914	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—metabolic syndrome X	5.07e-05	0.00091	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	5.06e-05	0.000909	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—metabolic syndrome X	4.98e-05	0.000894	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—metabolic syndrome X	4.97e-05	0.000893	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF2—metabolic syndrome X	4.88e-05	0.000876	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—metabolic syndrome X	4.81e-05	0.000864	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—metabolic syndrome X	4.78e-05	0.000857	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—metabolic syndrome X	4.75e-05	0.000853	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—metabolic syndrome X	4.75e-05	0.000853	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PLA2G6—metabolic syndrome X	4.62e-05	0.00083	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—metabolic syndrome X	4.61e-05	0.000828	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—metabolic syndrome X	4.61e-05	0.000828	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—metabolic syndrome X	4.59e-05	0.000824	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—metabolic syndrome X	4.58e-05	0.000822	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—metabolic syndrome X	4.58e-05	0.000821	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	4.48e-05	0.000804	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—metabolic syndrome X	4.43e-05	0.000795	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—VCAM1—metabolic syndrome X	4.41e-05	0.000792	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	4.38e-05	0.000786	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—metabolic syndrome X	4.31e-05	0.000774	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CD36—metabolic syndrome X	4.3e-05	0.000772	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TRIB3—metabolic syndrome X	4.25e-05	0.000764	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	4.24e-05	0.000762	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—metabolic syndrome X	4.24e-05	0.00076	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	4.2e-05	0.000754	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	4.16e-05	0.000748	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—metabolic syndrome X	4.13e-05	0.000742	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—metabolic syndrome X	4.04e-05	0.000724	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	3.9e-05	0.000701	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—metabolic syndrome X	3.88e-05	0.000697	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—metabolic syndrome X	3.84e-05	0.000689	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD36—metabolic syndrome X	3.77e-05	0.000678	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—APOA1—metabolic syndrome X	3.75e-05	0.000673	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—metabolic syndrome X	3.72e-05	0.000668	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—metabolic syndrome X	3.66e-05	0.000658	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD36—metabolic syndrome X	3.62e-05	0.000651	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—metabolic syndrome X	3.58e-05	0.000643	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—metabolic syndrome X	3.48e-05	0.000625	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	3.48e-05	0.000625	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	3.46e-05	0.000621	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CRP—metabolic syndrome X	3.4e-05	0.000611	CbGpPWpGaD
Auranofin—ALB—Metabolism—FMO3—metabolic syndrome X	3.4e-05	0.00061	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	3.36e-05	0.000603	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GCK—metabolic syndrome X	3.31e-05	0.000594	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CYBA—metabolic syndrome X	3.29e-05	0.000591	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	3.21e-05	0.000577	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—metabolic syndrome X	3.2e-05	0.000574	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	3.2e-05	0.000574	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CETP—metabolic syndrome X	3.19e-05	0.000573	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC3—metabolic syndrome X	3.16e-05	0.000567	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	3.13e-05	0.000563	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	3.12e-05	0.00056	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	3.09e-05	0.000555	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—metabolic syndrome X	3.08e-05	0.000552	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	3.04e-05	0.000545	CbGpPWpGaD
Auranofin—ALB—Metabolism—EPHX2—metabolic syndrome X	3.03e-05	0.000543	CbGpPWpGaD
Auranofin—ALB—Metabolism—MLXIPL—metabolic syndrome X	3.03e-05	0.000543	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	2.98e-05	0.000534	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS1—metabolic syndrome X	2.97e-05	0.000533	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—metabolic syndrome X	2.96e-05	0.000531	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	2.95e-05	0.00053	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS1—metabolic syndrome X	2.85e-05	0.000512	CbGpPWpGaD
Auranofin—ALB—Metabolism—G6PC2—metabolic syndrome X	2.85e-05	0.000511	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTNR1B—metabolic syndrome X	2.82e-05	0.000507	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TRIB3—metabolic syndrome X	2.75e-05	0.000494	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RBP4—metabolic syndrome X	2.75e-05	0.000494	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—metabolic syndrome X	2.73e-05	0.00049	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.71e-05	0.000486	CbGpPWpGaD
Auranofin—IKBKB—Immune System—VCAM1—metabolic syndrome X	2.68e-05	0.00048	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.62e-05	0.00047	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	2.57e-05	0.000462	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—metabolic syndrome X	2.52e-05	0.000452	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOB—metabolic syndrome X	2.44e-05	0.000439	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOC3—metabolic syndrome X	2.44e-05	0.000437	CbGpPWpGaD
Auranofin—ALB—Metabolism—FABP4—metabolic syndrome X	2.42e-05	0.000434	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLA2G4A—metabolic syndrome X	2.38e-05	0.000427	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—metabolic syndrome X	2.37e-05	0.000425	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD11B1—metabolic syndrome X	2.29e-05	0.000412	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.22e-05	0.000399	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	2.22e-05	0.000398	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CD36—metabolic syndrome X	2.22e-05	0.000398	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2C—metabolic syndrome X	2.2e-05	0.000395	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD36—metabolic syndrome X	2.2e-05	0.000395	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—metabolic syndrome X	2.18e-05	0.000391	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.16e-05	0.000388	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CYBA—metabolic syndrome X	2.13e-05	0.000382	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.12e-05	0.000381	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.11e-05	0.00038	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GHRL—metabolic syndrome X	2.08e-05	0.000374	CbGpPWpGaD
Auranofin—ALB—Metabolism—G6PD—metabolic syndrome X	2.04e-05	0.000367	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.02e-05	0.000362	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—metabolic syndrome X	2.01e-05	0.000361	CbGpPWpGaD
Auranofin—ALB—Metabolism—HDAC3—metabolic syndrome X	2e-05	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—metabolic syndrome X	1.98e-05	0.000356	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR1—metabolic syndrome X	1.97e-05	0.000354	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPA—metabolic syndrome X	1.95e-05	0.00035	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCKR—metabolic syndrome X	1.95e-05	0.00035	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOA1—metabolic syndrome X	1.93e-05	0.000347	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G6—metabolic syndrome X	1.89e-05	0.000339	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	1.88e-05	0.000337	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.88e-05	0.000337	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA5—metabolic syndrome X	1.87e-05	0.000336	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.82e-05	0.000326	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.78e-05	0.00032	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.78e-05	0.00032	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.76e-05	0.000316	CbGpPWpGaD
Auranofin—ALB—Metabolism—TRIB3—metabolic syndrome X	1.74e-05	0.000312	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS1—metabolic syndrome X	1.73e-05	0.000311	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.67e-05	0.0003	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—metabolic syndrome X	1.62e-05	0.00029	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—metabolic syndrome X	1.61e-05	0.00029	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOB—metabolic syndrome X	1.57e-05	0.000281	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAMPT—metabolic syndrome X	1.56e-05	0.00028	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.55e-05	0.000278	CbGpPWpGaD
Auranofin—ALB—Metabolism—LIPC—metabolic syndrome X	1.55e-05	0.000278	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCK—metabolic syndrome X	1.55e-05	0.000278	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOC3—metabolic syndrome X	1.54e-05	0.000276	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—metabolic syndrome X	1.53e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—metabolic syndrome X	1.53e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.52e-05	0.000274	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LPL—metabolic syndrome X	1.5e-05	0.000269	CbGpPWpGaD
Auranofin—ALB—Metabolism—CETP—metabolic syndrome X	1.49e-05	0.000268	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—metabolic syndrome X	1.46e-05	0.000263	CbGpPWpGaD
Auranofin—ALB—Metabolism—SCARB1—metabolic syndrome X	1.43e-05	0.000257	CbGpPWpGaD
Auranofin—ALB—Metabolism—SREBF1—metabolic syndrome X	1.39e-05	0.00025	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMGCR—metabolic syndrome X	1.35e-05	0.000243	CbGpPWpGaD
Auranofin—ALB—Metabolism—GOT2—metabolic syndrome X	1.35e-05	0.000243	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	1.31e-05	0.000234	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGT—metabolic syndrome X	1.28e-05	0.00023	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—metabolic syndrome X	1.24e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA1—metabolic syndrome X	1.24e-05	0.000223	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.22e-05	0.000219	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCA1—metabolic syndrome X	1.21e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A4—metabolic syndrome X	1.21e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Metabolism—GOT1—metabolic syndrome X	1.17e-05	0.00021	CbGpPWpGaD
Auranofin—ALB—Metabolism—GGT1—metabolic syndrome X	1.17e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—metabolic syndrome X	1.15e-05	0.000206	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS1—metabolic syndrome X	1.12e-05	0.000201	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—metabolic syndrome X	1.1e-05	0.000198	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—metabolic syndrome X	1.04e-05	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOB—metabolic syndrome X	9.9e-06	0.000178	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—metabolic syndrome X	9.84e-06	0.000177	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—metabolic syndrome X	9.68e-06	0.000174	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G4A—metabolic syndrome X	9.63e-06	0.000173	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPL—metabolic syndrome X	9.46e-06	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—metabolic syndrome X	9.39e-06	0.000169	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD36—metabolic syndrome X	8.98e-06	0.000161	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARA—metabolic syndrome X	8.35e-06	0.00015	CbGpPWpGaD
Auranofin—ALB—Metabolism—AGT—metabolic syndrome X	8.09e-06	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—metabolic syndrome X	7.93e-06	0.000142	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA1—metabolic syndrome X	7.84e-06	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—metabolic syndrome X	7.24e-06	0.00013	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—metabolic syndrome X	6.9e-06	0.000124	CbGpPWpGaD
Auranofin—ALB—Metabolism—INS—metabolic syndrome X	6.77e-06	0.000122	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—metabolic syndrome X	6.73e-06	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—metabolic syndrome X	6.68e-06	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—metabolic syndrome X	6.21e-06	0.000112	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—metabolic syndrome X	5.94e-06	0.000107	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—metabolic syndrome X	5.43e-06	9.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—metabolic syndrome X	4.68e-06	8.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—metabolic syndrome X	4.32e-06	7.75e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—metabolic syndrome X	2.73e-06	4.9e-05	CbGpPWpGaD
